Skip to main content
. 2011 Feb 22;6(2):e16384. doi: 10.1371/journal.pone.0016384

Table 1. Bronchoalveolar Lavage Patient Cohort.

Group Subject # Age Ethnicity Gender Smoking history FEV1 (%pred) FEV1/FVC Medications Approach Current Smoker
HS 1 53 C1 F 20 98 0.77 N Oral Yes
2 45 C1 F 16 103 0.80 N Nasal Yes
3 45 C1 M 20 114 0.93 N Nasal Yes
4 49 AI/NA2 F 40 102 0.76 N Nasal Yes
5 50 AA3 M 15 99 0.77 N Nasal Yes
6 47 C1 F 39 96 0.76 N Nasal Yes
7 66 C1 M 32 110 0.80 N Nasal No
CS 1 54 C1 M 120 79 0.63 ICS4/LAB5 Nasal No
2 62 C1 M 68 78 0.68 N Nasal Yes
3 40 AA3 M 25 79 0.67 N Oral Yes
4 60 C1 M 41 25 0.41 ICS4/LAB5 Oral No
NS 1 48 C1 F 0 105 0.86 N Nasal No
2 78 C1 F 0 83 0.77 N Nasal No
3 58 C1 F 0 142 0.80 N Nasal No
1

 = Caucasian;

2

 = American Indian/Native American;

3

 = African American;

4

 = Inhaled Corticosteroids;

5

 = Long Acting Beta-Agonists.